Published in J Clin Endocrinol Metab on April 01, 1992
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol (2015) 1.39
The circadian clock protein BMAL1 is necessary for fertility and proper testosterone production in mice. J Biol Rhythms (2008) 1.30
Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls. J Clin Endocrinol Metab (2008) 1.20
Progesterone directly and rapidly inhibits GnRH neuronal activity via progesterone receptor membrane component 1. Endocrinology (2012) 0.97
The Changes They are A-Timed: Metabolism, Endogenous Clocks, and the Timing of Puberty. Front Endocrinol (Lausanne) (2012) 0.97
Maturation of sleep-wake gonadotrophin-releasing hormone secretion across puberty in girls: potential mechanisms and relevance to the pathogenesis of polycystic ovary syndrome. J Neuroendocrinol (2010) 0.89
Perinatal environmental exposures affect mammary development, function, and cancer risk in adulthood. Annu Rev Pharmacol Toxicol (2011) 0.87
Nutrition and pubertal development. Indian J Endocrinol Metab (2014) 0.85
Insights into puberty: the relationship between sleep stages and pulsatile LH secretion. J Clin Endocrinol Metab (2012) 0.84
Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles. Gynecol Endocrinol (2013) 0.78
Role of seminiferous tubular development in determining the FSH versus LH responsiveness to GnRH in early sexual maturation. Neuroendocrinology (2009) 0.77
Arg-Phe-amide-related peptides influence gonadotropin-releasing hormone neurons. Neural Regen Res (2013) 0.75
The Effect of Bisphenol A on Puberty: A Critical Review of the Medical Literature. Int J Environ Res Public Health (2017) 0.75
Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet (2000) 4.34
Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A (2001) 2.35
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst (2000) 2.34
Child health, developmental plasticity, and epigenetic programming. Endocr Rev (2010) 2.15
Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res (1995) 2.08
Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab (1999) 2.07
Nutrition of the intervertebral disc: solute transport and metabolism. Connect Tissue Res (1981) 2.04
Population-based body mass index reference values from Göteborg, sweden: birth to 18 years of age. Acta Paediatr (2000) 1.92
Body mass index reference values (mean and SD) for Swedish children. Acta Paediatr (2001) 1.88
Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J (Clin Res Ed) (1984) 1.77
Diagnosis of ectopic pregnancy by vaginal ultrasonography in combination with a discriminatory serum hCG level of 1000 IU/l (IRP) Br J Obstet Gynaecol (1990) 1.65
Radioimmunoassay of plasma renin activity. Clin Chem (1976) 1.62
Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med (1997) 1.61
Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer (1986) 1.55
Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand (1986) 1.53
Normal early pregnancy: serum hCG levels and vaginal ultrasonography findings. Br J Obstet Gynaecol (1990) 1.53
Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum. Clin Chem (1999) 1.52
Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br J Obstet Gynaecol (1993) 1.51
Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction. Scand J Clin Lab Invest (2004) 1.47
Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer. Scand J Clin Lab Invest (2001) 1.47
Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin Chem (1995) 1.46
Correlation of HbA1C, glycated serum proteins and albumin, and fructosamine with the 24-h glucose profile of insulin-dependent pregnant diabetics. Clin Chem (1989) 1.45
Three assays for glycohemoglobin compared. Clin Chem (1995) 1.45
Growth hormone status in six children with fetal alcohol syndrome. Acta Paediatr (1996) 1.42
Effect of an in vitro fertilization program on serum CA 125, tumor-associated trypsin inhibitor, free beta-subunit of human chorionic gonadotropin, and common alpha-subunit of glycoprotein hormones. Fertil Steril (2000) 1.40
Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development. J Clin Endocrinol Metab (1997) 1.39
CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res (2002) 1.36
In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples. Urology (1996) 1.27
Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab (1996) 1.27
Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy. Int J Cancer (1983) 1.27
Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab (2001) 1.26
Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab (1993) 1.24
Target height as predicted by parental heights in a population-based study. Pediatr Res (1998) 1.23
Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem (1995) 1.21
Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab (1995) 1.21
Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab (1996) 1.20
Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab (2001) 1.20
Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem (1982) 1.20
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int J Cancer (1982) 1.16
Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology (1991) 1.15
Transvaginal sonography and serum hCG in monitoring of presumed ectopic pregnancies selected for expectant management. Ultrasound Obstet Gynecol (1995) 1.13
Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res (1992) 1.11
Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase. J Biol Chem (1989) 1.11
Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab (1988) 1.11
Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr (1997) 1.10
Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J Infect Dis (1996) 1.10
Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol (1995) 1.10
European randomized study of prostate cancer screening: first-year results of the Finnish trial. Br J Cancer (1999) 1.09
Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. Cancer Res (1991) 1.07
Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. J Clin Endocrinol Metab (2000) 1.07
Prevalence trends of obesity and overweight among 10-year-old children in western Sweden and relationship with parental body mass index. Acta Paediatr (2004) 1.06
Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases. Br J Cancer (1986) 1.06
New nomenclature for the human tissue kallikrein gene family. Clin Chem (2000) 1.06
Use of a rapid hCG-beta-subunit radioimmunoassay in acute gynaecological emergencies. Lancet (1980) 1.05
Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland. J Urol (2001) 1.04
Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study throughout puberty in healthy boys. J Clin Endocrinol Metab (1997) 1.03
Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab (1994) 1.02
Suppressed spontaneous secretion of growth hormone in girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child (1989) 1.02
Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids. J Clin Endocrinol Metab (1987) 1.01
Disappearance of human chorionic gonadotropin and its alpha- and beta-subunits after term pregnancy. Clin Chem (1997) 1.01
Postnatal growth and health in children born after cryopreservation as embryos. Lancet (1998) 1.00
Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer (1991) 0.99
Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med (1990) 0.99
Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J Pediatr (1992) 0.99
Ocular fundus morphology in preterm children. Influence of gestational age, birth size, perinatal morbidity, and postnatal growth. Invest Ophthalmol Vis Sci (1997) 0.99
Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA. Br J Cancer (1987) 0.98
Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin. Clin Chem (1993) 0.97
Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus. Gene Ther (2005) 0.97
Suspected ectopic pregnancy: ultrasound findings and hCG levels assessed by an immunofluorometric assay. Br J Obstet Gynaecol (1988) 0.97
Optimization of a time-resolved immunofluorometric assay for tumor-associated trypsin inhibitor (TATI) using the streptavidin-biotin system. J Immunol Methods (1993) 0.96
Preoperative serum concentration of hCGbeta as a prognostic factor in ovarian cancer. Int J Cancer (2001) 0.95
Patient evaluation of a new injection pen for growth hormone treatment in children and adults. Acta Paediatr Suppl (1995) 0.95
Serum human chorionic gonadotropin dynamics during spontaneous resolution of ectopic pregnancy. Fertil Steril (1994) 0.95
Activin A/erythroid differentiation factor is induced during human monocyte activation. J Exp Med (1992) 0.94
Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatr Res (2000) 0.94
Determination of urinary free cortisol by HPLC. Clin Chem (1997) 0.94
Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression. Int J Cancer (2001) 0.94
Length and body mass index at birth and target height influences on patterns of postnatal growth in children born small for gestational age. Pediatrics (1998) 0.94
Apparent C trisomy in bone marrow cells. Report of two cases. Scand J Haematol (1970) 0.94
Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Int J Cancer (1999) 0.94
Infancy growth pattern related to growth hormone deficiency. Acta Paediatr Scand (1988) 0.94
Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial. Br J Cancer (2009) 0.94
Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J Clin Endocrinol Metab (2000) 0.93